Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$262.92M
EBITDA Margin
-58.29%
TTM Avg
-89.32%
3Y Avg
-189.95%
5Y Avg
-208.07%
Market Cap
$265.78M
EBITDA Margin
-768.62%
TTM Avg
-551.06%
3Y Avg
-374.75%
5Y Avg
-290.29%
Market Cap
$266.59M
EBITDA Margin
-2882.46%
TTM Avg
-2207.86%
3Y Avg
-1135.55%
5Y Avg
-791.10%
Market Cap
$266.92M
EBITDA Margin
-2082.59%
TTM Avg
-1743.06%
3Y Avg
-1015.79%
5Y Avg
-806.48%
Market Cap
$261.43M
EBITDA Margin
-7643.91%
TTM Avg
-11162.31%
3Y Avg
-5581.16%
5Y Avg
-3720.77%
Market Cap
$261.27M
EBITDA Margin
-243.80%
TTM Avg
-818.13%
3Y Avg
-818.13%
5Y Avg
-1197.02%
Market Cap
$259.56M
EBITDA Margin
-50.56%
TTM Avg
-27.90%
3Y Avg
-8.82%
5Y Avg
-5.54%
Market Cap
$259.49M
EBITDA Margin
-20.52%
TTM Avg
-21.55%
3Y Avg
-22.69%
5Y Avg
-17.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scribe Therapeutics Inc. (SCTX) | $264.25M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -58.29% | -89.32% | -189.95% | -208.07% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | -768.62% | -551.06% | -374.75% | -290.29% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | -2882.46% | -2207.86% | -1135.55% | -791.10% |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | -2082.59% | -1743.06% | -1015.79% | -806.48% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | -7643.91% | -11162.31% | -5581.16% | -3720.77% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | -243.80% | -818.13% | -818.13% | -1197.02% |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | -50.56% | -27.90% | -8.82% | -5.54% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | -20.52% | -21.55% | -22.69% | -17.32% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | N/A | N/A | N/A | N/A |
Gross Margin
N/A
EBITDA Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
